Your browser doesn't support javascript.
loading
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.
Odaira, Koya; Yasuda, Takahiko; Okada, Kentaro; Shimooka, Takuya; Kojima, Yukino; Noura, Mina; Tamura, Shogo; Kurahashi, Shingo; Iwamoto, Eisuke; Sanada, Masashi; Matsumura, Itaru; Miyazaki, Yasushi; Kojima, Tetsuhito; Kiyoi, Hitoshi; Tsuzuki, Shinobu; Hayakawa, Fumihiko.
Affiliation
  • Odaira K; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Yasuda T; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Okada K; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Shimooka T; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kojima Y; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Noura M; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Tamura S; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan.
  • Iwamoto E; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sanada M; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Matsumura I; Department of Hematology and Rheumatology, Kindai University School of Medicine, Osaka, Japan.
  • Miyazaki Y; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Kojima T; Department of Integrated Health Sciences, Division of Cellular and Genetic Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kiyoi H; Aichi Health Promotion Foundation, Nagoya, Japan.
  • Tsuzuki S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hayakawa F; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Japan.
Cancer Sci ; 114(3): 781-792, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36341510
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / CCAAT-Enhancer-Binding Proteins Limits: Humans Language: En Journal: Cancer Sci Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia / CCAAT-Enhancer-Binding Proteins Limits: Humans Language: En Journal: Cancer Sci Year: 2023 Document type: Article Affiliation country: Country of publication: